ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 126

Ultrasonography of Salivary Glands: Diagnostic and Prognostic Value in Primary Sjögren’s Syndrome

Nicoletta Luciano1, Chiara Baldini1, Rachele Pascale2, Francesco Ferro1, Alessandro Paolicchi3, Davide Caramella3 and Stefano Bombardieri4, 1University of Pisa, Rheumatology Unit, Pisa, Italy, 2Department of Diagnostic and Interventional Radiology, University of Pisa, Pisa, Italy, 3Diagnostic and Interventional Radiology, University of Pisa, Pisa, Italy, 4Department of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Sjogren's syndrome and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases: Ultrasound, Nuclear Medicine and Fluorescence Imaging

Session Type: Abstract Submissions (ACR)

Background/Purpose: To assess the accuracy of ultrasonography of the salivary glands (US) in the diagnosis of primary Sjögren’s syndrome (pSS) and to verify whether US abnormalities can be correlated to patients’ clinical features, to the histopathological score of minor salivary gland biopsies and to the patients’ unstimulated sialometry of whole saliva.

Methods: Consecutive patients with a diagnosis of pSS made according to the AECG criteria were enrolled in the cross sectional prospective study. The control group consisted of subjects with suspected SS who did not fulfill the AECG criteria for pSS. US examination of the parotid and submandibular salivary glands was performed by a real-time US (Esaote Technos MPX) equipped with a 7.5/10 MHz linear transducer. The size, parenchymal echogenicity and fibrosis of major salivary glands were evaluated by the same observer who was not aware of the patients’ clinical diagnosis. Parenchymal inhomogeneity was assessed scoring as 0 = completely normal, 1 = slight abnormalities/few hypoechogenic areas, 2 = multiple hypoechogenic areas or 3 = many or confluent hypoechogenic lesions. US abnormalities were compared with patients’ clinico-serological data, sialometric findings and minor salivary gland focus score. For statistical comparisons, the t-test, the chi square test and logistic regression analysis were employed. P-values <0.05 were considered significant.

Results: Out of the 122 consecutive patients included in the study, 74/122 (71 F:3M, age 54.7±11.8 yrs) met the AECG criteria for pSS while the other 48/122 (45 F:3M, age 54.8±14.9 yrs) represented the control group. US abnormalities were found in 53/74 pSS patients vs 10/48 control group (p<0.0001); the grading values 2 and 3 resulted more frequent in the pSS group (36/74 vs 2/48; p<0.0001). Overall, the sensitivity of US was 71%, specificity 79% (96%, if we considered only parotid inhomogeneity), positive predictive value 84% and negative predictive value 64%. Parenchymal inhomogeneity of both parotid and submandibular glands correlated with antinuclear antibodies (ANA), anti-Ro/SSA, hypergammaglobulinemia and Rheumatoid Factor positivities. Patients with score 3 had significantly higher ESSDAI score (grade 3 vs 1, p=0.004; grade 3 vs 2, p=0.037) and showed trends towards lower salivary flow in comparison to other subgroups (grade 3 vs 1, p = 0.01; grade 3 vs grade 2, p= ns). When pSS patients where stratified according to parenchymal inhomogeneity, no difference was found in the presence of focal sialadenitis.

Conclusion: Major salivary glands US may be a specific tool in the diagnosis of pSS. US abnormalities should be investigated particularly in pSS patients with positive serological markers.


Disclosure:

N. Luciano,
None;

C. Baldini,
None;

R. Pascale,
None;

F. Ferro,
None;

A. Paolicchi,
None;

D. Caramella,
None;

S. Bombardieri,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasonography-of-salivary-glands-diagnostic-and-prognostic-value-in-primary-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology